Biomarkers in Irritable Bowel Syndrome: biological rationale and diagnostic value
R Nakov, V Snegarova, D Dimitrova-Yurukova… - Digestive …, 2022 - karger.com
Background: Patients with irritable bowel syndrome (IBS) usually suffer from nonspecific and
overlapping signs that hamper the diagnostic process. In line with this, biomarkers specific …
overlapping signs that hamper the diagnostic process. In line with this, biomarkers specific …
Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel …
Functional gastrointestinal disorders (FGID) such as functional dyspepsia (FD) and irritable
bowel syndrome (IBS) are highly prevalent and debilitating attributed to altered gut function …
bowel syndrome (IBS) are highly prevalent and debilitating attributed to altered gut function …
Neuronal‐enriched extracellular vesicles in individuals with IBS: A pilot study of COMT and BDNF
KR Weaver, M Mustapic, D Kapogiannis… - …, 2022 - Wiley Online Library
Background Irritable bowel syndrome (IBS) is characterized by abdominal pain, bowel habit
alterations, and psychiatric comorbidities. Although pathophysiology remains incompletely …
alterations, and psychiatric comorbidities. Although pathophysiology remains incompletely …
[PDF][PDF] Investigating Colonic Spirochaetosis in Association with Irritable Bowel Syndrome
KF MB - 2022 - nova.newcastle.edu.au
1.4. 2 Characterisation of CS 37 1.4. 3 Methods of CS diagnosis 43 1.4. 4 Symptoms of CS
46 1.4. 5 Prevalence and demographic of CS 47 Chapter 1 section 5 Pathological changes …
46 1.4. 5 Prevalence and demographic of CS 47 Chapter 1 section 5 Pathological changes …